These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 29274250)

  • 1. An Exosome-Based Vaccine Platform Imparts Cytotoxic T Lymphocyte Immunity Against Viral Antigens.
    Anticoli S; Manfredi F; Chiozzini C; Arenaccio C; Olivetta E; Ferrantelli F; Capocefalo A; Falcone E; Ruggieri A; Federico M
    Biotechnol J; 2018 Apr; 13(4):e1700443. PubMed ID: 29274250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor HPV E7-specific CTL activity elicited by in vivo engineered exosomes produced through DNA inoculation.
    Di Bonito P; Chiozzini C; Arenaccio C; Anticoli S; Manfredi F; Olivetta E; Ferrantelli F; Falcone E; Ruggieri A; Federico M
    Int J Nanomedicine; 2017; 12():4579-4591. PubMed ID: 28694699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA Vectors Generating Engineered Exosomes Potential CTL Vaccine Candidates Against AIDS, Hepatitis B, and Tumors.
    Ferrantelli F; Manfredi F; Chiozzini C; Anticoli S; Olivetta E; Arenaccio C; Federico M
    Mol Biotechnol; 2018 Nov; 60(11):773-782. PubMed ID: 30167966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineered exosomes emerging from muscle cells break immune tolerance to HER2 in transgenic mice and induce antigen-specific CTLs upon challenge by human dendritic cells.
    Anticoli S; Aricò E; Arenaccio C; Manfredi F; Chiozzini C; Olivetta E; Ferrantelli F; Lattanzi L; D'Urso MT; Proietti E; Federico M
    J Mol Med (Berl); 2018 Feb; 96(2):211-221. PubMed ID: 29282521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomes Enter Vaccine Development: Strategies Meeting Global Challenges of Emerging Infections.
    Jungbauer A
    Biotechnol J; 2018 Apr; 13(4):e1700749. PubMed ID: 29469213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A strategy of antigen incorporation into exosomes: comparing cross-presentation levels of antigens delivered by engineered exosomes and by lentiviral virus-like particles.
    Lattanzi L; Federico M
    Vaccine; 2012 Nov; 30(50):7229-37. PubMed ID: 23099330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strong CD8+ T cell antigenicity and immunogenicity of large foreign proteins incorporated in HIV-1 VLPs able to induce a Nef-dependent activation/maturation of dendritic cells.
    Sistigu A; Bracci L; Valentini M; Proietti E; Bona R; Negri DR; Ciccaglione AR; Tritarelli E; Nisini R; Equestre M; Costantino A; Marcantonio C; Santini SM; Lapenta C; Donati S; Tataseo P; Miceli M; Cara A; Federico M
    Vaccine; 2011 Apr; 29(18):3465-75. PubMed ID: 21382480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-tumor CD8+ T cell immunity elicited by HIV-1-based virus-like particles incorporating HPV-16 E7 protein.
    Di Bonito P; Grasso F; Mochi S; Petrone L; Fanales-Belasio E; Mei A; Cesolini A; Laconi G; Conrad H; Bernhard H; Dembek CJ; Cosma A; Santini SM; Lapenta C; Donati S; Muratori C; Giorgi C; Federico M
    Virology; 2009 Dec; 395(1):45-55. PubMed ID: 19800648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-Terminal Fatty Acids of NEF
    Chiozzini C; Manfredi F; Arenaccio C; Ferrantelli F; Leone P; Federico M
    Vaccines (Basel); 2020 May; 8(2):. PubMed ID: 32456079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPV-E7 delivered by engineered exosomes elicits a protective CD8⁺ T cell-mediated immune response.
    Di Bonito P; Ridolfi B; Columba-Cabezas S; Giovannelli A; Chiozzini C; Manfredi F; Anticoli S; Arenaccio C; Federico M
    Viruses; 2015 Mar; 7(3):1079-99. PubMed ID: 25760140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant Kunjin virus replicon vaccines induce protective T-cell immunity against human papillomavirus 16 E7-expressing tumour.
    Herd KA; Harvey T; Khromykh AA; Tindle RW
    Virology; 2004 Feb; 319(2):237-48. PubMed ID: 14980484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Antitumor CD8
    Ferrantelli F; Manfredi F; Chiozzini C; Leone P; Giovannelli A; Olivetta E; Federico M
    Cancers (Basel); 2021 May; 13(9):. PubMed ID: 34066801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strong SARS-CoV-2 N-Specific CD8
    Ferrantelli F; Chiozzini C; Manfredi F; Leone P; Spada M; Di Virgilio A; Giovannelli A; Sanchez M; Cara A; Michelini Z; Federico M
    Viruses; 2022 Feb; 14(2):. PubMed ID: 35215922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The C-Terminal Domain of Nef
    Chiozzini C; Manfredi F; Ferrantelli F; Leone P; Giovannelli A; Olivetta E; Federico M
    Vaccines (Basel); 2021 Apr; 9(4):. PubMed ID: 33921215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineered dendritic cells-derived exosomes harboring HIV-1 Nef
    Pordanjani PM; Bolhassani A; Pouriayevali MH; Milani A; Rezaei F
    Int J Biol Macromol; 2024 Jun; 270(Pt 2):132236. PubMed ID: 38768924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous CD8
    Ferrantelli F; Chiozzini C; Manfredi F; Giovannelli A; Leone P; Federico M
    Vaccines (Basel); 2021 Mar; 9(3):. PubMed ID: 33801926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Intracellular Delivery Of Anti-HPV16 E7 scFvs Through Engineered Extracellular Vesicles Inhibits The Proliferation Of HPV-Infected Cells.
    Ferrantelli F; Arenaccio C; Manfredi F; Olivetta E; Chiozzini C; Leone P; Percario Z; Ascione A; Flego M; Di Bonito P; Accardi L; Federico M
    Int J Nanomedicine; 2019; 14():8755-8768. PubMed ID: 31806970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Cancer Vaccine for HPV-Associated Neoplasms: Focus on a Therapeutic HPV Vaccine Based on a Novel Tumor Antigen Delivery Method Using Endogenously Engineered Exosomes.
    Di Bonito P; Accardi L; Galati L; Ferrantelli F; Federico M
    Cancers (Basel); 2019 Jan; 11(2):. PubMed ID: 30682811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor gene-engineered J558 tumor cell-released exosomes stimulate tumor antigen P1A-specific CD8+ CTL responses and antitumor immunity.
    Xie Y; Bai O; Zhang H; Li W; Xiang J
    Cancer Biother Radiopharm; 2010 Feb; 25(1):21-8. PubMed ID: 20187793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of human immunodeficiency virus type-1-specific immunity with a novel gene transport unit (GTU)-MultiHIV DNA vaccine.
    Blazevic V; Männik A; Malm M; Sikut R; Valtavaara M; Toots U; Ustav M; Krohn K
    AIDS Res Hum Retroviruses; 2006 Jul; 22(7):667-77. PubMed ID: 16831091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.